Omada Health (OMDA) Revenue & Revenue Breakdown
Omada Health Revenue Highlights
Latest Revenue (Y)
$169.80M
Latest Revenue (Q)
$68.03M
Omada Health Revenue by Period
Omada Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $169.80M | 38.29% |
| 2023-12-31 | $122.78M | 37.67% |
| 2022-12-31 | $89.19M | - |
Omada Health generated $169.80M in revenue during NA 2024, up 38.29% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Omada Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $68.03M | 10.85% |
| 2025-06-30 | $61.37M | 11.66% |
| 2025-03-31 | $54.96M | 14.56% |
| 2024-12-31 | $47.98M | 5.41% |
| 2024-09-30 | $45.52M | 10.44% |
| 2024-06-30 | $41.21M | 17.43% |
| 2024-03-31 | $35.09M | 7.83% |
| 2023-12-31 | $32.55M | -1.16% |
| 2023-09-30 | $32.93M | - |
Omada Health generated $68.03M in revenue during Q3 2025, up 10.85% compared to the previous quarter, and up 165.07% compared to the same period a year ago.
Omada Health Revenue Breakdown
Omada Health Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 25 |
|---|---|
| Hardware | $8.39M |
| Service | $56.96M |
Latest
Omada Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Service (87.16%), and Hardware (12.84%).
Omada Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TDOC | Teladoc Health | $2.57B | $626.44M |
| PGNY | Progyny | $1.17B | $313.35M |
| OMCL | Omnicell | $1.11B | $310.63M |
| TXG | 10x Genomics | $610.78M | $149.00M |
| UFPT | UFP | $504.42M | $154.56M |
| BCRX | BioCryst Pharmaceuticals | $450.71M | $159.40M |
| PHR | Phreesia | $419.81M | $117.25M |
| SDGR | Schrödinger | $207.54M | $54.76M |
| OMDA | Omada Health | $169.80M | $68.03M |
| MAZE | Maze Therapeutics | $167.50M | - |
| XERS | Xeris Biopharma | $163.91M | $71.54M |